Heparin prevents programmed cell death in human trophoblast

Molecular Human Reproduction

Volumn 12, Issue 4, 2006, Pages 237-243

  Hills, Frank A ^a,d   Abrahams, Vikki M ^b   González Timón, Belen ^a   Francis, Julia ^a   Cloke, Brianna ^a   Hinkson, Larry ^a   Rai, Raj ^c   Mor, Gil ^b   Regan, Lesley ^c   Sullivan, Mark ^a   Lam, Eric W F ^a   Brosens, Jan J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST MARY S HOSPITAL   (United Kingdom)

^d MIDDLESEX UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis; Heparin; Survival; Trophoblast

Indexed keywords

CASPASE 3; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; HEPARIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDOGLYCAN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE INHIBITOR; STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE; THROMBIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL LINE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NICK END LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TROPHOBLAST; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CASPASE 3; CASPASES; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; FEMALE; HEPARIN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PREGNANCY; SIGNAL TRANSDUCTION; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

STAPHYLOCOCCUS AUREUS;

EID: 33646883947     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gal026     Document Type: Article

References (55)

1. Abrahams VM, Bole-Aldo P, Kim YM, Straszewski-Chavez SL, Chaiworapongsa T, Romero R and Mor G (2004) Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol 173,4286-4296.
2. Allaire AD, Ballenger KA, Wells SR, McMahon MJ and Lessey BA (2000) Placental apoptosis in preeclampsia. Obstet Gynecol 96,271-276.
3. Arechavaleta-Velasco F, Koi H, Strauss JF III and Parry S (2002) Viral infection of the trophoblast: Time to take a serious look at its role in abnormal implantation and placentation? J Reprod Immunol 55,113-121.
4. Banerjee S, Smallwood A, Moorhead J, Chambers AE, Papageorghiou A, Campbell S and Nicolaides K (2005) Placental expression of interferongamma (IFN-gamma) and its receptor IFN-gamma R2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J Clin Endocrinol Metab 90,944-952.
5. Bose P, Black S, Kadyrov M, Bartz C, Shlebak A, Regan L and Huppertz B (2004) Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstet Gynecol 191,2125-2131.
6. Bose P, Black S, Kadyrov M, Weissenborn U, Neulen J, Regan L and Huppertz B (2005) Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure. Am J Obstet Gynecol 192,23-30.
7. Chamley LW, Duncalf AM, Mitchell MD and Johnson PM (1998) Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 352,1037-1038.
8. Choi BC, Polgar K, Xiao L and Hill JA (2000) Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 15 (Suppl. 1),46-59.
9. Choi HK, Choi BC, Lee SH, Kim JW, Cha KY and Baek KH (2003) Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev 66,24-31.
10. Christopherson KW II, Campbell JJ, Travers JB and Hromas RA (2002) Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration. J Pharmacol Exp Ther 302,290-295.
11. von Dadelszen P and Magee LA (2002) Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 81,642-648.
12. Di Simone N, Ferrazzani S, Castellani R, De Carolis S, Mancuso S and Caruso A (1997) Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Hum Reprod 12,2061-2065.
13. Di Simone N, Castellani R, Caliandro D and Caruso A (2001) Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 65,1766-1770.
14. Di Simone N, Castellani R, Caliandro D and Caruso A (2002) Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules. Fertil Steril 77,805-811.
15. Di Simone N, Raschi E, Testoni C, Castellani R, D'Asta M, Shi T, Krilis SA, Caruso A and Meroni PL (2005) Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Ann Rheum Dis 64,462-467.
16. Folkman J and Shing Y (1992) Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol 313,355-364.
17. Fritchley SJ, Kirby JA and Ali S (2000) The antagonism of interferon-gamma (IFN-gamma) by heparin: Examination of the blockade of class II MHC antigen and heat shock protein-70 expression. Clin Exp Immunol 120,247-252.
18. Girardi G (2005) Heparin treatment in pregnancy loss: Potential therapeutic benefits beyond anticoagulation. J Reprod Immunol 66,45-51.
19. Girardi G, Redecha P and Salmon JE (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10,1222-1226.
20. Goncalves LF, Chaiworapongsa T and Romero R (2002) Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 8,3-13.
21. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N and Lala PK (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206,204-211.
22. Greer I and Hunt BJ (2005) Low molecular weight heparin in pregnancy: current issues. Br J Haematol 128,593-601.
23. Hills FA, Elder MG, Chard T and Sullivan MH (2004) Regulation of human villous trophoblast by insulin-like growth factors and insulin-like growth factor-binding protein-1. J Endocrinol 183,487-496.
24. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T and Maruo T (2002) Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186,158-166.
25. Ishikawa Y and Kitamura M (1999) Inhibition of glomerular cell apoptosis by heparin. Kidney Int 56,954-963.
26. Johann S, Zoller C, Haas S, Blumel G, Lipp M and Forster R (1995) Sulfated polysaccharide anticoagulants suppress natural killer cell activity in vitro. Thromb Haemost 74,998-1002.
27. Johnstone ED, Mackova M, Das S, Payne SG, Lowen B, Sibley CP, Chan G and Guilbert LJ (2005) Multiple anti-apoptotic pathways stimulated by EGF in villous trophoblasts. Placenta 26,548-555.
28. Krabbendam I, Franx A, Bots ML, Fijnheer R and Bruinse HW (2005) Thrombophilias and recurrent pregnancy loss: A critical appraisal of the literature. Eur J Obstet Gynecol Reprod Biol 118,143-153.
29. Labied S, Kajihara T, Madureira PA, Fusi L, Jones MC, Higham JM, Varshochi R, Francis JM, Zoumpoulidou G, Essafi A et al. (2005) Progestins regulate the expression and activity of the Forkhead transcription factor FOXO1 in differentiating human endometrium. Mol Endocrinol [Epub ahead of print].
30. Leach RE, Romero R, Kim YM, Chaiworapongsa T, Kilburn B, Das SK, Dey SK, Johnson A, Qureshi F, Jacques S et al. (2002) Pre-eclampsia and expression of heparin-binding EGF-like growth factor. Lancet 360,1215-1219.
31. Lee J, Choi BC, Cho C, Hill JA, Baek KH and Kim JW (2005) Trophoblast apoptosis is increased in women with evidence of TH1 immunity. Fertil Steril 83,1047-1049.
32. Leung DN, Smith SC, To KF, Sahota DS and Baker PN (2001) Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 184,1249-1250.
33. Li Y, Wang HY and Cho CH (1999) Association of heparin with basic fibroblast growth factor, epidermal growth factor, and constitutive nitric oxide synthase on healing of gastric ulcer in rats. J Pharmacol Exp Ther 290,789-796.
34. Li Y, Wang WP, Wang HY and Cho CH (2000) Intragastric administration of heparin enhances gastric ulcer healing through a nitric oxide-dependent mechanism in rats. Eur J Pharmacol 399,205-214.
35. Manduteanu I, Voinea M, Capraru M, Dragomir E and Simionescu M (2002) A novel attribute of enoxaparin: Inhibition of monocyte adhesion to endothelial cells by a mechanism involving cell adhesion molecules. Pharmacology 65,32-37.
36. Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF and Abbate R (2005) Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45,86-91.
37. Meroni PL, di Simone N, Testoni C, D'Asta M, Acaia B and Caruso A (2004) Antiphospholipid antibodies as cause of pregnancy loss. Lupus 13,649-652.
38. Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, Tanaka Y, Yagi H, Sonoda K, Kai M et al. (2004) Heparin-binding EGFlike growth factor is a promising target for ovarian cancer therapy. Cancer Res 64,5720-5727.
39. Quenby S, Mountfield S, Cartwright JE, Whitley GS and Vince G (2004) Effects of low-molecular-weight and unfractionated heparin on trophoblast function. Obstet Gynecol 104,354-361.
40. Quenby S, Mountfield S, Cartwright JE, Whitley GS, Chamley L and Vince G (2005) Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril 83,691-698.
41. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M and Farhat R (2000) Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 15,713-718.
42. Rai R and Regan L (2002) Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment. Obstet Gynecol 100,1354.
43. Rai R, Cohen H, Dave M and Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314,253-257.
44. Rey E, Kahn SR, David M and Shrier I (2003) Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 361,901-908.
45. Rossignol P, Bouton MC, Jandrot-Perrus M, Bryckaert M, Jacob MP, Bezeaud A, Guillin MC, Michel JB and Meilhac O (2004) A paradoxical proapoptotic effect of thrombin on smooth muscle cells. Exp Cell Res 299,279-285.
46. Sebire NJ, Fox H, Backos M, Rai R, Paterson C and Regan L (2002) Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 17,1067-1071.
47. Shriver Z, Sundaram M, Venkataraman G, Fareed J, Linhardt R, Biemann K and Sasisekharan R (2000) Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin. Proc Natl Acad Sci USA 97,10365-10370.
48. Smirnova IV, Zhang SX, Citron BA, Arnold PM and Festoff BW (1998) Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons. J Neurobiol 36,64-80.
49. Smith SC, Baker PN and Symonds EM (1997a) Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 177,57-65.
50. Smith SC, Baker PN and Symonds EM (1997b) Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 177,1395-1401.
51. Straszewski-Chavez SL, Abrahams VM and Mor G (2005) The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev 26,877-897.
52. Tzafettas J, Mamopoulos A, Anapliotis A, Loufopoulos A, Psarra A, Klearchou N and Mamopoulos M (2002) Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology. Clin Exp Obstet Gynecol 29,267-270.
53. Wan JG, Mu JS, Zhu HS and Geng JG (2002) N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo. Inflamm Res 51,435-443.
54. Yamamoto H, Fuyama S, Arai S and Sendo F (1985) Inhibition of mouse natural killer cytotoxicity by heparin. Cell Immunol 96,409-417.
55. Yui J, Garcia-Lloret M, Wegmann TG and Guilbert LJ (1994) Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 15,819-835.